Literature DB >> 17879322

A flk-1 promoter/enhancer reporter transgenic Xenopus laevis generated using the Sleeping Beauty transposon system: an in vivo model for vascular studies.

Joanne R Doherty1, Michelle R Johnson Hamlet, Emin Kuliyev, Paul E Mead.   

Abstract

We have used the Sleeping Beauty (SB) transposable element to generate transgenic Xenopus laevis with expression of green fluorescent protein (GFP) in vascular endothelial cells using the frog flk-1 promoter. This is the first characterization of a SB-generated transgenic Xenopus that has tissue-restricted expression. We demonstrate that the transgene integrated into single genomic loci in two independent founder lines and is transmitted through the germline at the expected Mendelian frequencies. Transgene integration occurred through a noncanonical transposition process possibly reflecting Xenopus-specific interactions with the SB system. The transgenic animals express GFP in the same spatial and temporal pattern as the endogenous flk-1 gene throughout development and into adulthood. Overexpression of xVEGF122 in the transgenic animals disrupts vascular development that is visualized by fluorescent microscopy. These studies demonstrate the convenience of the SB system for generating transgenic animals and the utility of the xflk-1:GFP transgenic line for in vivo studies of vascular development. 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17879322     DOI: 10.1002/dvdy.21321

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  19 in total

1.  pTransgenesis: a cross-species, modular transgenesis resource.

Authors:  Nick R Love; Raphael Thuret; Yaoyao Chen; Shoko Ishibashi; Nitin Sabherwal; Roberto Paredes; Juliana Alves-Silva; Karel Dorey; Anna M Noble; Matthew J Guille; Yoshiki Sasai; Nancy Papalopulu; Enrique Amaya
Journal:  Development       Date:  2011-12       Impact factor: 6.868

2.  Notch signaling, wt1 and foxc2 are key regulators of the podocyte gene regulatory network in Xenopus.

Authors:  Jeffrey T White; Bo Zhang; Débora M Cerqueira; Uyen Tran; Oliver Wessely
Journal:  Development       Date:  2010-04-28       Impact factor: 6.868

3.  Optimized transgenesis in Xenopus laevis/gilli isogenetic clones for immunological studies.

Authors:  Hristina Nedelkovska; Jacques Robert
Journal:  Genesis       Date:  2011-12-27       Impact factor: 2.487

Review 4.  Xenopus pronephros development--past, present, and future.

Authors:  Oliver Wessely; Uyen Tran
Journal:  Pediatr Nephrol       Date:  2011-04-17       Impact factor: 3.714

Review 5.  Transposon tools hopping in vertebrates.

Authors:  Jun Ni; Karl J Clark; Scott C Fahrenkrug; Stephen C Ekker
Journal:  Brief Funct Genomic Proteomic       Date:  2008-11

Review 6.  Transposon transgenesis in Xenopus.

Authors:  Donald A Yergeau; Clair M Kelley; Haiqing Zhu; Emin Kuliyev; Paul E Mead
Journal:  Methods       Date:  2010-03-04       Impact factor: 3.608

7.  'In parallel' interconnectivity of the dorsal longitudinal anastomotic vessels requires both VEGF signaling and circulatory flow.

Authors:  Tomasz Zygmunt; Sean Trzaska; Laura Edelstein; Johnathon Walls; Saathyaki Rajamani; Nicholas Gale; Laura Daroles; Craig Ramírez; Florian Ulrich; Jesús Torres-Vázquez
Journal:  J Cell Sci       Date:  2012-08-16       Impact factor: 5.285

8.  Transgenesis in Xenopus using the Sleeping Beauty transposon system.

Authors:  Donald A Yergeau; Michelle R Johnson Hamlet; Emin Kuliyev; Haiqing Zhu; Joanne R Doherty; Taylor D Archer; Andrea P Subhawong; Marc B Valentine; Clair M Kelley; Paul E Mead
Journal:  Dev Dyn       Date:  2009-07       Impact factor: 3.780

9.  Diverse functions of kindlin/fermitin proteins during embryonic development in Xenopus laevis.

Authors:  Tania Rozario; Paul E Mead; Douglas W DeSimone
Journal:  Mech Dev       Date:  2014-08-28       Impact factor: 1.882

10.  Remobilization of Tol2 transposons in Xenopus tropicalis.

Authors:  Donald A Yergeau; Clair M Kelley; Emin Kuliyev; Haiqing Zhu; Amy K Sater; Dan E Wells; Paul E Mead
Journal:  BMC Dev Biol       Date:  2010-01-22       Impact factor: 1.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.